MétaCan
Menu
Back to cohort
Record W4409601948 · doi:10.1136/egastro-2024-100179

Pentoxifylline use in alcohol-associated hepatitis with acute kidney injury does not improve survival: a global study

2025· letter· en· W4409601948 on OpenAlexaff
Francisco Idalsoaga, Luis Antonio Díaz, Winston Dunn, Heer H. Mehta, Vicente Caldentey, Jorge Arnold, Gustavo Ayares, Shiv Kumar Sarin, Rakhi Maiwall, Wei Zhang, Steve Qian, Douglas A. Simonetto, Ashwani K. Singal, Mohamed A. Elfeki, Rokhsana Mortuza, Gurpreet Malhi, Alvi H. Islam, Leonardo Guizzetti, Carolina Ramírez, Joaquín Cabezas, María Poca, Berta Cuyàs, Germán Soriano, Meritxell Ventura‐Cots, María Fátima Higuera-De La Tijera, Juan G. Abraldeṣ, Mustafa Al‐Karaghouli, Ľubomír Skladaný, Daniel Ján Havaj, Diego Rincón, Vijay H. Shah, Marco Arrese, Patrick S. Kamath, Ramón Bataller, Juan Pablo Arab

Bibliographic record

VenueeGastroenterology · 2025
Typeletter
Languageen
FieldMedicine
TopicAlcohol Consumption and Health Effects
Canadian institutionsUniversity of AlbertaLondon Health Sciences CentreWestern University
FundersFondo Nacional de Desarrollo Científico y Tecnológico
KeywordsMedicinePentoxifyllineInternal medicineAlcoholic hepatitisAcute kidney injuryProportional hazards modelLiver transplantationLiver diseaseCirrhosisAlcoholic liver diseaseSurgeryGastroenterologyTransplantation

Abstract

fetched live from OpenAlex

Background: Severe alcohol-associated hepatitis (sAH) is a life-threatening condition with high mortality, where corticosteroid use is the only treatment that has shown short-term benefits. Pentoxifylline, an anti-tumour necrosis factor-alpha agent, has been proposed for its potential to improve outcomes, especially in patients with acute kidney injury (AKI). We aimed to evaluate the impact of pentoxifylline on mortality in patients with sAH and AKI in a well-characterised global cohort. Methods: We conducted a retrospective, registry-based study including patients meeting the National Institute on Alcohol Abuse and Alcoholism clinical criteria for sAH and AKI. Mortality was the primary endpoint, with liver transplantation as a competing risk. Statistical analysis included Cox regression and Kaplan-Meier survival estimates. Results: We included 525 patients from 20 centres across eight countries. The median age was 48 years, with 26.1% females, and 76.9% had a history of cirrhosis. Multivariable Cox regression models showed that pentoxifylline use was not associated with survival (HR 1.20, 95% CI 0.85 to 1.69, p=0.291). Factors associated with mortality included age (HR 1.23, 95% CI 1.10 to 1.36, p<0.001), Model for End-Stage Liver Disease score at admission (HR 1.06, 95% CI 1.04 to 1.08, p<0.001) and renal replacement therapy use (HR 1.39, 95% CI 1.05 to 1.84, p=0.019). The main causes of death were multiple organ failure (42%), infections (10%), oesophageal varices bleeding (7%) and renal failure (6%). Conclusion: Pentoxifylline showed no significant benefit on mortality in patients with sAH and AKI. Further studies are needed to refine treatment strategies for this high-risk group.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Research integrity
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Commentary · Consensus signal: none
Teacher disagreement score0.378
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.003
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.039
GPT teacher head0.352
Teacher spread0.313 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueeGastroenterologySame topicAlcohol Consumption and Health EffectsFrench-language works237,207